Keyphrases
Liver
100%
Secretome
100%
Gene Signature
100%
Liver Disease Severity
100%
Circulating Biomarkers
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Signature-based
100%
Gene Products
23%
Patient Cohort
15%
Global Gene Expression
15%
Lipoproteins
7%
Disease Diagnosis
7%
Obese Men
7%
Insulin-like
7%
Differentially Expressed
7%
Plasma Samples
7%
Binding Protein
7%
Publicly Available
7%
Gene Expression Changes
7%
Disease-based
7%
Between-person
7%
Non-invasive Biomarkers
7%
Morbid Obesity
7%
Growth Factor Binding
7%
Diagnostic Biomarker
7%
RNA Sequencing (RNA-seq)
7%
Mild Fibrosis
7%
Selective Expression
7%
Disease Biomarker
7%
Monitoring Disease Progression
7%
Biomarker Candidates
7%
Serpin
7%
Bioinformatics pipeline
7%
Nonalcoholic Fatty Liver Disease Activity Score
7%
Bioanalysis
7%
Liver Transcriptome
7%
Yield Potential
7%
Liver Selective
7%
Hepatic Genes
7%
Selective Secretion
7%
S-adenosylmethionine Decarboxylase
7%
Biochemistry, Genetics and Molecular Biology
Gene Product
100%
Secretome
100%
Gene Signature
100%
Gene Expression
66%
Candidate Gene
66%
Secretion (Process)
33%
Methionine
33%
Transcriptome
33%
Synapsin I
33%
Insulin-Like Growth Factor-Binding Protein
33%
RNA Sequence
33%
Serpin
33%
Lipoprotein(A)
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Disease Severity
100%
Nonalcoholic Fatty Liver
100%
Lipoprotein A
7%
Disease Activity Score
7%
Disease Exacerbation
7%
Fibrosis
7%
Transcriptome
7%
Serine Proteinase Inhibitor
7%
RNA-Sequencing
7%
Somatomedin Binding Protein 1
7%
Methionine Adenosyltransferase
7%
Immunology and Microbiology
Secretome
100%
Non-Alcoholic Fatty Liver Disease
100%
Gene Product
21%
Blood Plasma
14%
Gene Expression
14%
Protein Binding
7%
Secretion (Process)
7%
Somatomedin
7%
Transcriptome
7%
RNA Sequence
7%
Serpin
7%